Details of the Drug

General Information of Drug (ID: DMW7UL0)

• Drug Name: Ixmyelocel-T
• Synonyms: Bone marrow-derived stem cell therapy, Aastrom; Bone marrow-derived stem cell therapy (limb ischemia), Aastrom; Bone marrow-derived CRCs (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived cardiac repair cells (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived stem cell therapy (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived TRC's (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived tissue repair cells, (cardiac regeneration/dilated cardiomyopathy), Aastrom

Indication

Disease Entry	ICD 11	Status	REF
Dilated cardiomyopathy	BC43.0	Phase 3	[1]
Type-1 diabetes	5A10	Phase 3	[2]
Heart failure	BD10-BD13	Phase 2	[3]

• Cross-matching ID: TTD ID: D09MHN
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT01483898) An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI). U.S. National Institutes of Health.
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)